Loader Background
Request a demo
Learn more

Meet our team

Our leadership team has an extensive background in medical, orthopedics, neurosurgery, and spine surgery robotics.

Our team

Founders

Bertin Nahum

Quantum Surgical Co-founder & CEO

Bertin Nahum

Quantum Surgical Co-founder & CEO

Successful entrepreneur in Surgical Robotics :

Prior to Quantum Surgical, Bertin NAHUM founded Medtech SA (Rosa® Surgical Robot – neuro and spine surgery) in 2002, took the company public (IPO) in 2013 and sold it to Zimmer Biomet (NYSE: ZBH) in 2016.

Previously, he pioneered the development of robot-assisted solutions in various surgical specialties at Computer Motion Inc. (Zeus, AESOP – laparoscopic surgery) and Integrated Surgical Systems Inc. (ROBODOC – orthopedic surgery).

Bertin Nahum graduated from the National Institute of Applied Sciences (FR) and holds a Master of Science in Robotics and a Doctorate of Technology Honoris Causa from Coventry University (UK).

He was awarded the Legion of Honor in the rank of Chevalier in 2013.

Fernand Badano

Quantum Surgical Co-founder & General Manager

Fernand Badano

Quantum Surgical Co-founder & General Manager

Fernand has 25+ years of experience as Chief Operating Officer and on the Board of Directors of multiple innovative medical technology companies.

He served as General Manager and Board Director of Medtech SA.

Fernand Badano holds a PhD degree from National Institute of Applied Sciences (FR).

Lucien Blondel

Quantum Surgical Co-founder & CTO

Lucien Blondel

Quantum Surgical Co-founder & CTO
Get in touch

Lucien Blondel has over 20 years of experience in medical imaging and robotics.

He led R&D for Medtech SA and also worked for GE Healthcare in their Imaging division.

Lucien Blondel is graduated from the Centrale-Supélec Engineering school (FR).

Sophie Roca

Quantum Surgical Co-founder & Executive Assistant

Sophie Roca

Quantum Surgical Co-founder & Executive Assistant
Get in touch

Sophie Roca has 10+ years experience as Executive assistant of Medtech SA.

She graduated with a Masters Degree in Psychology and University Degree in Neurobiology & Neurosciences.

Our team

Leadership

Christophe Sibillin

Chief Financial Officer

Christophe Sibillin

Chief Financial Officer
Get in touch

Christophe Sibillin has 20+ years experience in Finance (IPO-M&A) within medical and high-tech industries.

Previous experience includes Chief Financial Officer and General Manager at Medtech SA as well as Finance Director at Supersonic Imagine SA.

 

Laetitia Messner

Chief Clinical Officer

Laetitia Messner

Chief Clinical Officer
Get in touch

Laetitia Messner has 10+ years experience in the Public Health Sector.

She was head of the Hospital Information Systems Policy for the French Ministry of Health, and COO of Montpellier University Hospital.

Laetitia MESSNER graduated from the Ecole Polytechnique Engineering school (FR).

Noah Hewitt

US Chief Commercial Officer

Noah Hewitt

US Chief Commercial Officer
Get in touch

Noah Hewitt is an accomplished healthcare executive with extensive experience in the medical device industry and a proven track record of success in large, mid-size, and startup sales organizations.

Prior to joining Quantum Surgical, Noah Hewitt held various positions in sales & marketing at Medtronic, Covidien, and Tyco Healthcare across North America.

Marion Sabrou

HR Director

Marion Sabrou

HR Director
Get in touch

Previously, Marion MOLLET held HR positions in international companies from various industries.

Hervé Cointement

EMEA Sales Director

Hervé Cointement

EMEA Sales Director
Get in touch

Hervé Cointement has 30+ years experience in medical devices sales.

Previously Andras held the position of EMEA Strategic Account Manager at Zimmer Biomet Robotics and EMEA Manager Capital Equipment at St. Jude Medical.

 

Elise Lagacherie

Quality & Regulatory Affairs Director

Elise Lagacherie

Quality & Regulatory Affairs Director
Get in touch

Elise Lagacherie has 15+ years experience in Quality & Regulatory Affairs.

She was QQ and RA Manager at Medtech SA and prior to that she worked for Beckman Coulter.

Andras Lukacs

Director of Engineering

Andras Lukacs

Director of Engineering
Get in touch

Andras Lukacs has 15+ years’ experience in medical Software & System Engineering.

Previously Andras held the position of System & IT Healthcare Director at Fresenius Kabi and Senior Software Manager at GE Healthcare.

 

Our team

Board Members

Bertin Nahum

Quantum Surgical Co-founder & CEO

Bertin Nahum

Quantum Surgical Co-founder & CEO

Successful entrepreneur in Surgical Robotics :

Prior to Quantum Surgical, Bertin NAHUM founded Medtech SA (Rosa® Surgical Robot – neuro and spine surgery) in 2002, took the company public (IPO) in 2013 and sold it to Zimmer Biomet (NYSE: ZBH) in 2016.

Previously, he pioneered the development of robot-assisted solutions in various surgical specialties at Computer Motion Inc. (Zeus, AESOP – laparoscopic surgery) and Integrated Surgical Systems Inc. (ROBODOC – orthopedic surgery).

Bertin Nahum graduated from the National Institute of Applied Sciences (FR) and holds a Master of Science in Robotics and a Doctorate of Technology Honoris Causa from Coventry University (UK).

He was awarded the Legion of Honor in the rank of Chevalier in 2013.

Fernand Badano

Quantum Surgical Co-founder & General Manager

Fernand Badano

Quantum Surgical Co-founder & General Manager

Fernand has 25+ years of experience as Chief Operating Officer and on the Board of Directors of multiple innovative medical technology companies.

He served as General Manager and Board Director of Medtech SA.

Fernand Badano holds a PhD degree from National Institute of Applied Sciences (FR).

Lucien Blondel

Quantum Surgical Co-founder & CTO

Lucien Blondel

Quantum Surgical Co-founder & CTO
Get in touch

Lucien Blondel has over 20 years of experience in medical imaging and robotics.

He led R&D for Medtech SA and also worked for GE Healthcare in their Imaging division.

Lucien Blondel is graduated from the Centrale-Supélec Engineering school (FR).

Frank Yu

Ally Bridge Group Founder, CEO & CIO

Frank Yu

Ally Bridge Group Founder, CEO & CIO

Frank is Founder, CEO and CIO of Ally Bridge Group (ABG), a leading global life sciences investment specialist having generated billions of dollars of value from its life science investments in China, the US and Europe, integrated between the private and public markets. ABG is dual-headquartered in New York and Hong Kong, also with teams in California and Israel. Frank and his team excel in leading high-impact life science transactions with a strong focus on the world’s most cutting-edge life science innovations at later stages, primarily in the US, and in deal-making between emerging technologies and industry giants, and across geographies.

Prior to founding and running Ally Bridge, Frank was a Managing Director at Goldman Sachs, then at Och-Ziff Capital where he was Head of China Investments. Previously, Frank had worked at Credit Suisse in Hong Kong and London, Moody’s and Thomson Financial in New York.

With a passion for art and world cultures and commitment to philanthropy, Frank serves on the Board of Trustees to the Solomon R. Guggenheim Foundation.

Andrew Pang

Ally Bridge Group Principal

Andrew Pang

Ally Bridge Group Principal

Andrew Pang is a Principal of Ally Bridge Group and focuses on medical devices investments and private equity transactions. He joined the team led by Frank Yu in 2011 and has since played an important role in underwriting and executing notable transactions including the take-private of WuXi Pharmatech and Shandong Luoxin Pharmaceutical as well as the Series C investment in GRAIL, Inc. Before joining ABG, Mr. Pang worked at InterLeader, a family-office investment group in Hong Kong, focusing on private equity transactions. Prior to returning to Hong Kong, Mr. Pang worked at Bank of America in London, where he worked on European leveraged buyout transactions. Mr. Pang has developed excellent deal execution skills and cross-border investment experience. Mr. Pang holds a BA in Mathematics and Computer Science from the University of Cambridge where he graduated with first class honors.

Our team

Scientific Advisory Board

Prof. Steven D. Colquhoun (USA)

Surgeon

Prof. Steven D. Colquhoun (USA)

Surgeon

Prof. Steven D. Colquhoun is Liver Transplant Surgeon, specialized in robotic surgery at Cedars-Sinai Medical Center. He completed fellowship training in both transplantation and surgical oncology at UCLA. He is board certified in both surgery and critical care.

Dr. Colquhoun is involved in clinical and translational research aimed at improving both the diagnosis and treatment of hepatocellular carcinoma as well as other primary and metastatic liver tumors such as colorectal cancer and neuroendocrine tumors.

Prof. Thierry de Baere (FR)

Interventional radiologist

Prof. Thierry de Baere (FR)

Interventional radiologist

Prof. Thierry de Baere is Head of the Therapeutic Imaging Department (interventional radiology) at Gustave Roussy Cancer Center.

Prof. de Baère devotes his work to minimally invasive therapies in the treatment of kidney, lung, and liver cancers. He focuses mainly on intra-arterial therapies for primary and secondary liver tumors and percutaneous liver tumor ablation with radiofrequency and cryoablation.

Prof. Boris Guiu (FR)

Diagnostic & Interventional Radiologist

Prof. Boris Guiu (FR)

Diagnostic & Interventional Radiologist

Prof. Boris Guiu Head of Department of Diagnostic and Interventional Radiology at St-Eloi Hospital – CHU Montpellier and Professor at the Faculty of Medicine of Montpellier since 2014, his clinical activity and his research work focus on liver imaging and hepatic interventional radiology.

Boris GUIU is a member of several national and international scientific societies in the field of digestive and interventional radiology and is a guest speaker at many international congresses in this field. He has published more than 160 articles in peer-reviewed journals.

He has coordinated several phase I and II therapeutic trials in the field of locoregional therapies in oncology, notably through two national PHRCs obtained in 2016 and 2017. Boris GUIU recently described a new technique allowing to obtain a 60% increase in liver function in just 7 days. Finally, the first 4D Interventional Radiology Room in Europe was installed in his department.

Prof. Nishita Kothary (USA)

Interventional Radiologist

Prof. Nishita Kothary (USA)

Interventional Radiologist

Prof. Nishita Kothary is a Professor of Radiology in the section of Interventional Radiology at Stanford University Medical Center.

Dr. Kothary’s clinical practice primarily focuses on percutaneous and endovascular therapies for primary and metastatic liver cancer. Her research interests lie in radiogenomics and in the use of advanced imaging in the diagnosis and treatment of hepatocellular carcinoma (HCC).

Prof. David C. Madoff (USA)

Interventional Radiologist

Prof. David C. Madoff (USA)

Interventional Radiologist

Prof. David C. Madoff is Section Chief, Interventional Radiology at Yale New Haven Hospital and Vice Chairman for Clinical Research Department of Radiology and biomedical imaging at Yale School of medicine.

Previously, he was Vice Chairman for Academic Affairs and Professor of Radiology at Weill Cornell Medicine. From January 2011 to November 2015, David C. Madoff served as Chief of the Division of Interventional Radiology.

He is an internationallyrecognized expert in Interventional Oncology.

Dr. David C. Madoff is a leader in academic Interventional Radiology and has been an invited speaker at numerous national and international meetings. He authored or co-authored over 100 peer-reviewed scientific articles, has written more than 30 book chapters and served as co-editor of three textbooks including the highly regarded textbook entitled Venous Embolization of the Liver: Radiologic and Surgical Practice and the newly released textbook entitled Clinical Interventional Oncology.  David C. Madoff currently serves as Deputy Editor for RADIOLOGY, the flagship scientific journal of the Radiological Society of North America (RSNA) and served as Deputy Editor-in-Chief of the Journal of Vascular and Interventional Radiology from 2007 to 2010.

Dr. David C. Madoff is active in many of the major radiological societies including the Radiological Society of North America, the American Roentgen Ray Society, the Society of Interventional Radiology and the Association of University Radiologists. Based on his important contributions to the field, David C. Madoff was elected Fellow of the Society of Interventional Radiology in 2007 and Fellow of the American College of Radiology in 2015.

Prof. Luigi Solbiati (IT)

Interventional Radiologist

Prof. Luigi Solbiati (IT)

Interventional Radiologist

Luigi Solbiati worked from 1980 to 2015 at the General Hospital of Busto Arsizio (Varese), rising from Assistant Radiologist to Chairman of the Department of Oncology and Head of the Division of Interventional Oncologic Radiology.

He pioneered ultrasound-guided aspiration biopsies (1979), ethanol injection (1983), radiofrequency ablation with cool-tip electrodes (1995) and microwaves (2009) of solid tumors and fusion imaging for the guidance of interventional procedures (2003). In parallel, he has been serving as an adjunct Professor of “Techniques and Methods of Diagnostic Imaging” from 1988 to 2014 at the School of Radiology of the University of Milan.

He gave more than 480 scientific presentations at Meetings, Congresses and Courses in 23 countries. He has been Guest Lecturer at the Universities of San Diego, Zurich, Beijing, Hong Kong, New Delhi, Cairo, Vienna, Yale and at the Mayo Clinic (Rochester). Chairman of the 1st World Conference on Interventional Oncology (Cernobbio, Italy) in 2006. Chairman of the 1st Interventional Oncology Sans Frontieres Congress (IOSFC) (Cernobbio, Italy) in 2013.

Prof. Guy Vallancien (FR)

Urology Surgeon

Prof. Guy Vallancien (FR)

Urology Surgeon

Honorary Member 

Formerly Head of Department of Montsouris Institute. Guy Vallancien is recognized as an international pioneer in the development of laparoscopic and robotic surgery for prostate, kidney and bladder cancers.

Guy Vallancien is a Member of the French National Academy of Medicine and Member of the Parliamentary Office for the Evaluation of Scientific and Technological Choices (OPECST).

He is the founder and President of the Convention on Health Analysis and Management, CHAM and Honorary Professor of Universities.

Guy VALLANCIEN founded the European school of surgery in 2001.

He has been decorated with the awards of « Officer of the Legion of Honour » in 2010 and « Officer of the national order of merit »  in 2016.

Careers

Quantum Surgical is recruiting

At Quantum Surgical, we are recruiting the brightest minds and most creative innovators that thrive in a start-up environment.